Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $1.22 million. The enterprise value is -$3.82 million.
| Market Cap | 1.22M |
| Enterprise Value | -3.82M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APVO has 4.08 million shares outstanding. The number of shares has increased by 330.29% in one year.
| Shares Outstanding | 4.08M |
| Shares Change (YoY) | +330.29% |
| Shares Change (QoQ) | +146.97% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 0.04% |
| Float | 4.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.20 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.92 |
| Quick Ratio | n/a |
| Debt / Equity | 0.85 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -219.20% and return on invested capital (ROIC) is -248.35%.
| Return on Equity (ROE) | -219.20% |
| Return on Assets (ROA) | -109.70% |
| Return on Capital (ROIC) | -248.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$675,475 |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.52% in the last 52 weeks. The beta is 5.26, so APVO's price volatility has been higher than the market average.
| Beta (5Y) | 5.26 |
| 52-Week Price Change | -99.52% |
| 50-Day Moving Average | 0.74 |
| 200-Day Moving Average | 6.45 |
| Relative Strength Index (RSI) | 22.09 |
| Average Volume (20 Days) | 424,445 |
Short Selling Information
The latest short interest is 21,105, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 21,105 |
| Short Previous Month | 47,668 |
| Short % of Shares Out | 0.52% |
| Short % of Float | 0.52% |
| Short Ratio (days to cover) | 0.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.11M |
| Pretax Income | -27.02M |
| Net Income | -27.02M |
| EBITDA | -26.52M |
| EBIT | -27.02M |
| Earnings Per Share (EPS) | -$92.23 |
Balance Sheet
The company has $10.25 million in cash and $5.21 million in debt, giving a net cash position of $5.04 million or $1.23 per share.
| Cash & Cash Equivalents | 10.25M |
| Total Debt | 5.21M |
| Net Cash | 5.04M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | 6.10M |
| Book Value Per Share | 1.50 |
| Working Capital | 5.78M |
Cash Flow
| Operating Cash Flow | -22.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | -22.95M |
| FCF Per Share | -$33.42 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -330.29% |
| Shareholder Yield | -330.29% |
| Earnings Yield | -2,221.89% |
| FCF Yield | -1,887.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 6, 2024. It was a reverse split with a ratio of 1:44.
| Last Split Date | Mar 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:44 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |